Investor Backing & Capital Strength:
Recent Series B financing led by a tier‑one investor and total funding of $50M indicate a strong capital position to support scaling. Announced plans link this capital to product and market expansion through 2025–2026.
Market Expansion:
Public materials describe serving large patient volumes across dozens of states and adding specialties beyond behavioral health into areas like home health, long‑term care, and substance use care. Partnerships and broader specialty positioning suggest widening distribution and reach.
Strong Hiring & Retention:
Active job postings into 2026 and multiple open roles point to ongoing team expansion aligned with go‑to‑market and operations scale‑up. Company and aggregator pages consistently show a growing employee band.
